SCHEMBL25925934

SCHEMBL25925934

Cc1nsc(/N=N/c2ccc(O)c(O)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
HSP90AA1 P07900 3/20 0.41
GAA P10253 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HTT P42858 2/20 0.35
PDE4A P27815 1/20 0.35
BLVRB P30043 1/20 0.35
KDR P35968 1/20 0.35
MAPT P10636 5/20 0.35
SNCA P37840 1/20 0.35
ATP4A P20648 4/20 0.35
ATP4B P51164 4/20 0.35
BRD4 O60885 2/20 0.35
TRPA1 O75762 1/20 0.34
HPGD P15428 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14255077 0.86 PTGS2 (0.46) PTGS2PTGS1MEN1KMT2ANPC1
SCHEMBL30595630 0.86 PTGS2 (0.46) PTGS2PTGS1MEN1KMT2ANPC1
SCHEMBL24504568 0.80 PTGS2 (0.39) PTGS2PTGS1MEN1KMT2ANPC1
SCHEMBL16351447 0.80 BRD4 (0.39) MEN1KMT2ANPC1RAB9AHSP90AA1
SCHEMBL14543228 0.80 THRB (0.41) MEN1KMT2ANPC1RAB9AHSP90AA1
SCHEMBL14517095 0.79 L3MBTL1 (0.36) PTGS2MEN1KMT2ANPC1RAB9A
SCHEMBL16232515 0.74 BRD4 (0.40) PTGS2PTGS1MEN1KMT2ANPC1
SCHEMBL25925915 0.73 MEN1 (0.54) MEN1KMT2ANPC1RAB9AHSP90AA1
SCHEMBL25925895 0.72 AHR (0.32) HSP90AA1L3MBTL1CCR6
SCHEMBL15049576 0.72 MEN1 (0.32) MEN1KMT2ANPC1RAB9AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 PTGS2 3678/4885PTGS1 1753/4885MEN1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.